Related Experiment Video
Updated: Jan 30, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Addressing the critical need for cancer genetic evaluation by implementation of an embedded coordinator-based
Amy Wiegand1, Karina Brierley1, Kharla Colon-Vazquez1
1Smilow Cancer Genetics and Prevention Program, Yale New Haven Health, New Haven, Connecticut, USA.
A new Fast-Track program using clinical genetics coordinators significantly reduced wait times for hereditary cancer genetic testing. This model, overseen by genetic counselors, improves access to timely cancer predisposition testing.
Area of Science:
- Oncology
- Genetics
- Healthcare Delivery Models
Background:
- Increasing indications for germline genetic testing (GT) for hereditary cancer predispositions are straining resources.
- A critical shortage of genetic counselors (GCs) necessitates innovative alternative delivery models for genetic services.
- The Smilow Cancer Genetics and Prevention Program (SCGP) sought to improve efficiency in GT.
Purpose of the Study:
- To design, implement, and evaluate a coordinator-based alternative GT delivery model, the Fast-Track Program.
- To assess the impact of the Fast-Track Program on reducing wait times for GT appointments.
- To ensure standard-of-care delivery for cancer GT under GC oversight within the new model.
Main Methods:
- Implemented a Fast-Track Program utilizing trained clinical genetics coordinators (GCCs) for pre-test education and GT coordination.
- GCs triaged referrals based on National Comprehensive Cancer Network (NCCN) guidelines.
- Patients received an educational video, and GCCs coordinated testing; GCs reviewed all cases post-visit for management recommendations.
Main Results:
- The Fast-Track Program saw 415 patients over 9 months, with 12.3% identifying pathogenic/likely pathogenic variants (PGVs).
- Mean days from referral to appointment were significantly shorter in the Fast-Track program (21.92 days) compared to the standard GC pipeline (90.14 days) (p < 0.001).
- GCs managed complex results or PGVs, while GCCs handled disclosure for uncomplicated cases.
Conclusions:
- A coordinator-based genetics delivery model successfully expedited GT visits and is expanding.
- GC oversight is crucial for maintaining standard-of-care in cancer GT within this model.
- Further evaluation of outcomes like patient satisfaction is needed to fully contextualize the model's impact.
Related Concept Videos
Genetics of Speciation
What is Population Genetics?
What is Genetic Engineering?
Animal Mitochondrial Genetics
Types of Genetic Transfer Between Organisms
Area Computation by the Alternative Coordinate Method

